Ireland's Elan is considering selling its development and manufacturing division for around $1.5 billion, a move that would leave the company devoted to its bio-pharmaceuticals business. Report [1]
Links:
[1] http://www.ft.com/cms/s/0/bacb43aa-552a-11dd-ae9c-000077b07658.html